Invesco Ltd. C4 Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 64,546 shares of CCCC stock, worth $278,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,546

Previous 65,499 1.45%

Holding current value

$278,193

Previous $302,000 21.52%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.43 - $7.38 $4,221 - $7,033	-953 Reduced 1.45%	64,546 $367,000
Q2 2024 Aug 13, 2024	BUY	$4.05 - $8.1 $109,200 - $218,400	26,963 Added 69.97%	65,499 $302,000
Q1 2024 May 14, 2024	SELL	$5.3 - $11.0 $3.46 Million - $7.19 Million	-653,546 Reduced 94.43%	38,536 $314,000
Q4 2023 Feb 12, 2024	BUY	$1.18 - $6.03 $750,115 - $3.83 Million	635,691 Added 1127.29%	692,082 $3.91 Million
Q3 2023 Nov 13, 2023	BUY	$1.81 - $3.89 $870 - $1,871	481 Added 0.86%	56,391 $104,000
Q2 2023 Aug 11, 2023	SELL	$2.75 - $3.77 $37,259 - $51,079	-13,549 Reduced 19.51%	55,910 $153,000
Q1 2023 May 12, 2023	BUY	$3.1 - $9.02 $165,022 - $480,161	53,233 Added 328.07%	69,459 $218,000
Q4 2022 Feb 13, 2023	SELL	$5.42 - $10.24 $162 - $307	-30 Reduced 0.18%	16,226 $95,000
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $19,280 - $30,660	2,401 Added 17.33%	16,256 $142,000
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $630,258 - $3.3 Million	-124,557 Reduced 89.99%	13,855 $105,000
Q1 2022 May 16, 2022	SELL	$19.99 - $33.23 $6.51 Million - $10.8 Million	-325,790 Reduced 70.18%	138,412 $3.36 Million
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $185,774 - $296,202	-6,321 Reduced 1.34%	464,202 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $40,506 - $56,964	1,128 Added 0.24%	470,523 $21 Million
Q2 2021 Aug 17, 2021	SELL	$30.39 - $42.18 $4.26 Million - $5.92 Million	-140,324 Reduced 23.01%	469,395 $17.8 Million
Q1 2021 May 17, 2021	BUY	$31.96 - $46.5 $9.88 Million - $14.4 Million	309,177 Added 102.87%	609,719 $22.6 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $6.85 Million - $11.1 Million	300,542 New	300,542 $9.96 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $211M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account